Table 3.
Influenza virus | Respiratory syncytial virus | Human metapneumo-virus | Human rhinovirus | |
---|---|---|---|---|
Cough | + + | + + | + + | |
Headache | + | – | – | |
Rhinorrhoea | + | + | + | |
Dyspnoea | – | + + | ||
Conjunctivitis | + | |||
Period of onset of symptoms | ||||
Before influenza epidemic | – – – | +++ | + | +++ |
During influenza epidemic | a | a | a | a |
After influenza epidemic | – – – | + + | + | |
Age group (years) | ||||
<5 | – | +++ | +++ | + |
5–14 | + | + | – | |
15–29 | ||||
30–44 | a | a | a | a |
45–64 | + + + | + + | ||
≥65 | + + + | + + + | ||
Influenza vaccination (for current season) | – |
Adjusted OR significantly >1: ‘+’ for 1 < OR < 2; ‘+ +’ for 2 ≤ OR < 3; ‘+ + +’ for OR ≥ 3. Adjusted OR significantly <1: ‘–’ for 0.5 < OR < 1; ‘– –’ for 0.3 < OR ≤ 0.5; ‘– – –’ for OR ≤ 0.3.
Reference group.